Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C16H12O6 |
| Molecular Weight | 300.2629 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC=C(C=C1O)C2=CC(=O)C3=C(O2)C=C(O)C=C3O
InChI
InChIKey=MBNGWHIJMBWFHU-UHFFFAOYSA-N
InChI=1S/C16H12O6/c1-21-13-3-2-8(4-10(13)18)14-7-12(20)16-11(19)5-9(17)6-15(16)22-14/h2-7,17-19H,1H3
| Molecular Formula | C16H12O6 |
| Molecular Weight | 300.2629 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Diosmetin is the aglycone of the flavonoid glycoside diosmin, which occurs naturally in citrus fruits. Diosmetin is found in the legume Acacia farnesiana Wild and Olea europaea L. leaves. Diosmin is hydrolyzed to its aglycone diosmetin by intestinal microflora enzymes before its absorption into the body. Pharmacologically, diosmetin is reported to exhibit anticancer, antimicrobial, antioxidant, oestrogenic and anti-inflammatory activities. Diosmetin increased inhibitory GSK-3beta phosphorylation, while selectively reducing gamma-secretase activity, Abetta generation, tau hyperphosphorylation and pro-inflammatory activation of microglia in vitro, without altering Notch processing. Therefore, diosmetin could be considered as potential candidate for novel anti- Alzheimer's disease therapy. Diosmetin is ER-beta agonist and potential novel drug for the acute myeloid leukemia treatment.
CNS Activity
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL2231 Sources: https://www.ncbi.nlm.nih.gov/pubmed/20696580 |
140.0 nM [IC50] | ||
Target ID: CHEMBL3356 Sources: https://www.ncbi.nlm.nih.gov/pubmed/20696580 |
2.4 µM [IC50] | ||
Target ID: CHEMBL4878 Sources: https://www.ncbi.nlm.nih.gov/pubmed/20696580 |
29.0 nM [IC50] | ||
Target ID: CHEMBL242 Sources: https://www.ncbi.nlm.nih.gov/pubmed/28835383 |
|||
Target ID: map04064 Sources: https://www.ncbi.nlm.nih.gov/pubmed/28101238 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Unknown Approved UseUnknown |
|||
| Preventing | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
PubMed
| Title | Date | PubMed |
|---|---|---|
| In vitro effects of some flavones on human pyruvate kinase isoenzyme M2. | 2015-03 |
|
| Comparative CYP1A1 and CYP1B1 substrate and inhibitor profile of dietary flavonoids. | 2011-05-01 |
|
| Beta-glucuronidase from Helix pomatia origin is not suitable for diosmetin analysis. | 2010-12-01 |
|
| Effects of plant-derived polyphenols on TNF-alpha and nitric oxide production induced by advanced glycation endproducts. | 2010-07 |
|
| Why do we need multifunctional neuroprotective and neurorestorative drugs for Parkinson's and Alzheimer's diseases as disease modifying agents. | 2010-06 |
|
| Flavonoids and antioxidant activity of Rosa agrestis leaves. | 2010-04 |
|
| Simultaneous determination of diosmin and diosmetin in human plasma by ion trap liquid chromatography-atmospheric pressure chemical ionization tandem mass spectrometry: Application to a clinical pharmacokinetic study. | 2010-03-11 |
|
| Managing phenol contents in crop plants by phytochemical farming and breeding-visions and constraints. | 2010-03-02 |
|
| Effects of Various Flavonoids on the α-Synuclein Fibrillation Process. | 2010-01-28 |
|
| Flavonoids diosmetin and hesperetin are potent inhibitors of cytochrome P450 2C9-mediated drug metabolism in vitro. | 2010 |
|
| [Chemical constituents of Galium verum]. | 2009-11 |
|
| [Studies on flavones from Flos Chrysanthemi Indici]. | 2009-10 |
|
| Cytotoxic activity of flavonoids from the flowers of Chrysanthemum morifolium on human colon cancer Colon205 cells. | 2009-09 |
|
| [Chemical constituents of Lobelia chinensis]. | 2009-09 |
|
| Antioxidant Activity of Caffeic Acid through a Novel Mechanism under UVA Irradiation. | 2009-07 |
|
| Cytochrome P450 CYP1A1: wider roles in cancer progression and prevention. | 2009-06-16 |
|
| Anticancer effects of the flavonoid diosmetin on cell cycle progression and proliferation of MDA-MB 468 breast cancer cells due to CYP1 activation. | 2009-06 |
|
| Flavonoids and cinnamic acid derivatives as inhibitors of 17beta-hydroxysteroid dehydrogenase type 1. | 2009-03-25 |
|
| Trihydroxynaphthalene reductase of Curvularia lunata--a target for flavonoid action? | 2009-03-16 |
|
| The phytochemical analysis and antioxidant activity assessment of orange peel (Citrus sinensis) cultivated in Greece-Crete indicates a new commercial source of hesperidin. | 2009-03 |
|
| Bioactivation of the phytoestrogen diosmetin by CYP1 cytochromes P450. | 2009-02-08 |
|
| [Studies on chemical components of Lobelia chinensis]. | 2009-02 |
|
| Ecdysteroids and a sucrose phenylpropanoid ester from Froelichia floridana. | 2009-02 |
|
| Acasiane A and B and farnesirane A and B, diterpene derivatives from the roots of Acacia farnesiana. | 2009-02 |
|
| Aurintricarboxylic acid inhibits influenza virus neuraminidase. | 2009-02 |
|
| Simultaneous determination of the flavonoid aglycones diosmetin and hesperetin in human plasma and urine by a validated GC/MS method: in vivo metabolic reduction of diosmetin to hesperetin. | 2009-02 |
|
| Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases. | 2009-01-08 |
|
| Stimulatory constituents of Eclipta prostrata on mouse osteoblast differentiation. | 2009-01 |
|
| Oregano: a source for peroxisome proliferator-activated receptor gamma antagonists. | 2008-12-24 |
|
| A new ferulic acid ester and other constituents from Dracocephalum peregrinum. | 2008-10 |
|
| Effect of flavonoids on rat splenocytes, a structure-activity relationship study. | 2008-08-15 |
|
| Flavonoids from Galium verum L. | 2008-07-19 |
|
| Camptothecinoids from the seeds of Taiwanese Nothapodytes foetida. | 2008-06-16 |
|
| New features on the fragmentation and differentiation of C-glycosidic flavone isomers by positive electrospray ionization and triple quadrupole mass spectrometry. | 2008-06 |
|
| Diosmetin induces human osteoblastic differentiation through the protein kinase C/p38 and extracellular signal-regulated kinase 1/2 pathway. | 2008-06 |
|
| Prediction of intestinal absorption and metabolism of pharmacologically active flavones and flavanones. | 2008-04-01 |
|
| Plant-derived polyphenols attenuate lipopolysaccharide-induced nitric oxide and tumour necrosis factor production in murine microglia and macrophages. | 2008-04 |
|
| Flavonoids diosmetin and luteolin inhibit midazolam metabolism by human liver microsomes and recombinant CYP 3A4 and CYP3A5 enzymes. | 2008-03-15 |
|
| [Studies on chemical constituents in Huangjuhua (flowers of Chrysanthemum morifolium)]. | 2008-03 |
|
| Different flavonoids present in the micronized purified flavonoid fraction (Daflon 500 mg) contribute to its anti-hyperpermeability effect in the hamster cheek pouch microcirculation. | 2008-02 |
|
| Two new flavonoids from Origanum vulgare. | 2008 |
|
| Complete assignments of NMR data of 13 hydroxymethoxyflavones. | 2007-12 |
|
| A new flavone glycoside from the fruits of Luffa cylindrica. | 2007-12 |
|
| Raddeanalin, a new flavonoid glycoside from the leaves of Salix raddeana Laksh. | 2007-08-19 |
|
| Pensteminoside, an unusual catalpol-type iridoid from Penstemon gentianoides HBK (Plantaginaceae). | 2007-07 |
|
| Anti-proliferative and antioxidant constituents from Tecoma stans. | 2007-02-14 |
|
| Flavonoids modulate monocarboxylate transporter-1-mediated transport of gamma-hydroxybutyrate in vitro and in vivo. | 2007-02 |
|
| Inhibition of pro-inflammatory markers in primary bone marrow-derived mouse macrophages by naturally occurring flavonoids: analysis of the structure-activity relationship. | 2006-10-16 |
|
| The efflux of flavonoids morin, isorhamnetin-3-O-rutinoside and diosmetin-7-O-beta-D-xylopyranosyl-(1-6) -beta-D-glucopyranoside in the human intestinal cell line caco-2. | 2006-08 |
|
| Polar constituents from the aerial parts of Origanum vulgare L. Ssp. hirtum growing wild in Greece. | 2006-07-26 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/28835383
Mice: 50mg /kg/every other day for 6 weeks
Route of Administration:
Intraperitoneal
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/19424633
Diosmetin caused G1 arrest at 10 microM in MDA-MB 468 cells after 48-h treatment whereas this effect was not observed in MCF-10A cells.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:48:14 GMT 2025
by
admin
on
Mon Mar 31 18:48:14 GMT 2025
|
| Record UNII |
TWZ37241OT
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
DSLD |
4156 (Number of products:7)
Created by
admin on Mon Mar 31 18:48:14 GMT 2025 , Edited by admin on Mon Mar 31 18:48:14 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
SUB35834
Created by
admin on Mon Mar 31 18:48:14 GMT 2025 , Edited by admin on Mon Mar 31 18:48:14 GMT 2025
|
PRIMARY | |||
|
8101
Created by
admin on Mon Mar 31 18:48:14 GMT 2025 , Edited by admin on Mon Mar 31 18:48:14 GMT 2025
|
PRIMARY | |||
|
DIOSMETIN
Created by
admin on Mon Mar 31 18:48:14 GMT 2025 , Edited by admin on Mon Mar 31 18:48:14 GMT 2025
|
PRIMARY | |||
|
DTXSID80199966
Created by
admin on Mon Mar 31 18:48:14 GMT 2025 , Edited by admin on Mon Mar 31 18:48:14 GMT 2025
|
PRIMARY | |||
|
TWZ37241OT
Created by
admin on Mon Mar 31 18:48:14 GMT 2025 , Edited by admin on Mon Mar 31 18:48:14 GMT 2025
|
PRIMARY | |||
|
100000128590
Created by
admin on Mon Mar 31 18:48:14 GMT 2025 , Edited by admin on Mon Mar 31 18:48:14 GMT 2025
|
PRIMARY | |||
|
5281612
Created by
admin on Mon Mar 31 18:48:14 GMT 2025 , Edited by admin on Mon Mar 31 18:48:14 GMT 2025
|
PRIMARY | |||
|
4630
Created by
admin on Mon Mar 31 18:48:14 GMT 2025 , Edited by admin on Mon Mar 31 18:48:14 GMT 2025
|
PRIMARY | |||
|
1314347
Created by
admin on Mon Mar 31 18:48:14 GMT 2025 , Edited by admin on Mon Mar 31 18:48:14 GMT 2025
|
PRIMARY | RxNorm | ||
|
520-34-3
Created by
admin on Mon Mar 31 18:48:14 GMT 2025 , Edited by admin on Mon Mar 31 18:48:14 GMT 2025
|
PRIMARY | |||
|
TWZ37241OT
Created by
admin on Mon Mar 31 18:48:14 GMT 2025 , Edited by admin on Mon Mar 31 18:48:14 GMT 2025
|
PRIMARY | |||
|
4601
Created by
admin on Mon Mar 31 18:48:14 GMT 2025 , Edited by admin on Mon Mar 31 18:48:14 GMT 2025
|
PRIMARY | |||
|
208-291-8
Created by
admin on Mon Mar 31 18:48:14 GMT 2025 , Edited by admin on Mon Mar 31 18:48:14 GMT 2025
|
PRIMARY | |||
|
m4594
Created by
admin on Mon Mar 31 18:48:14 GMT 2025 , Edited by admin on Mon Mar 31 18:48:14 GMT 2025
|
PRIMARY | Merck Index | ||
|
C039602
Created by
admin on Mon Mar 31 18:48:14 GMT 2025 , Edited by admin on Mon Mar 31 18:48:14 GMT 2025
|
PRIMARY | |||
|
DB11259
Created by
admin on Mon Mar 31 18:48:14 GMT 2025 , Edited by admin on Mon Mar 31 18:48:14 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> IMPURITY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |